HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Cancer Research
Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention
Molecular Cancer Therapeutics
Molecular Cancer Research
Cancer Prevention Research
Cancer Prevention Journals Portal
Cancer Reviews Online
Annual Meeting Education Book
Meeting Abstracts Online
Cancer Research
65, , , . doi:
© 2009
American Association for Cancer Research
This Article
Abstract
Full Text
Services
Email this article to a friend
Alert me to new issues of the journal
In vitro
Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants
Cancer Res O'Hare et al. 65: 4500
Supplementary Data, O'Hare et al.
Files in this Data Supplement:
Supplementary Figure 1
Supplementary Figure 2
This Article
Abstract
Full Text
Services
Email this article to a friend
Alert me to new issues of the journal
HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Cancer Research
Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention
Molecular Cancer Therapeutics
Molecular Cancer Research
Cancer Prevention Research
Cancer Prevention Journals Portal
Cancer Reviews Online
Annual Meeting Education Book
Meeting Abstracts Online